Gisoo Ghaffari is a Rheumatology/Immunology physician affiliated with Pennsylvania State University. OpenAlex indexes 67 publications with 469 citations (h-index 13); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
80.6%Leukotriene Receptor Antagonist19.4%Montelukast Sodium100%Part D<11 patientsbeta2-Adrenergic Agonist18.8%Albuterol Sulfate Hfa100%Part D≥12 patients+ 4 more classes in this area
Dermatology
12.7%Interleukin-4 Receptor alpha Antagonist12.7%Dupixent Syringe100%Part D<11 patientsBlood & clotting
6.7%Salt solutions6.7%Sodium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Treatment of eosinophilic esophagitis with immune modulating agents
Allergy and Asthma Proceedings
2026 - Should we follow the penicillin allergy label trail in approaching patients with a sulfonamide allergy label?
Allergy and Asthma Proceedings
2026 - Racial and ethnic disparities in sublingual immunotherapy prescriptions for allergic rhinitis in the United States
The Journal of Allergy and Clinical Immunology In Practice
2025 - Impact of sulfonamide allergy label on clinical outcomes of acute cystitis: a retrospective matched cohort study
Internal Medicine Journal
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Legro, MD
Pennsylvania State University
Ramin Zand, MD, MPH
Pennsylvania State University
Allan Lipton, MD
Pennsylvania State University
Steven Ettinger, MD
Pennsylvania State University
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”